ENDPOINTS

After research pivot, Biogen beefs up pipeline with Stoke's late-stage Dravet candidate

A month after Biogen signaled plans to shift its attention to "external opportunities," it delivered on that ambition. The drugmaker said Tuesday it's paying ...

Feb 18, 2025 - 16:08
 0
After research pivot, Biogen beefs up pipeline with Stoke's late-stage Dravet candidate
A month after Biogen signaled plans to shift its attention to "external opportunities," it delivered on that ambition. The drugmaker said Tuesday it's paying ...
Read More

Tags:

Previous Article

‘Triangle of death’: will Italy finally tackle mafia’s toxic waste dumping?

Next Article

'Hugely proud': UK Paralympian becomes 1st disabled astronaut to be cleared for ...

Related Posts

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Eli Lilly stockpiles $548M of oral weight loss drug ahe...

Feb 21, 2025  0

FDA approves Ono’s rare joint tumor drug, setting up battle with Daiichi

FDA approves Ono’s rare joint tumor drug, setting up ba...

Feb 18, 2025  0

Kevin Tang's Concentra tries to disrupt proposed Acelyrin-Alumis merger

Kevin Tang's Concentra tries to disrupt proposed Acelyr...

Feb 21, 2025  0